otid stenosis in this
patient group and the efficacy of CEA for clinically
significant lesions in reducing overall stroke (GRADE 1,
Level of Evidence A).
2. Imaging should be strongly considered for patients who
present with amaurosis fugax, evidence of retinal artery
embolization on funduscopic examination, or asymptomatic cerebral infarction, and are candidates for CEA.
This recommendation is based on the intermediate
stroke risk in this group of patients and